SANTA CLARA, Calif. — Agilent Technologies, Inc. (NYSE: A) has received notice of an unsolicited mini-tender offer by TRC Capital Corporation to purchase up to 2.5 million shares, or about 0.75%, of Agilent Technologies, Inc. outstanding common stock at a price of $41.55 per share in cash. As TRC Capital’s own offer document acknowledges, the […]

Palo Alto, CA – Centrillion Technologies, a genomic technologies company, has received a SBIR grant from the National Human Genome Research Institute, part of the National Institutes of Health (NIH). The grant will help fund the company’s ongoing research efforts in the development of breakthrough genomic technologies, including phased sequencing of complete genomes using specially […]

WILMINGTON, Mass. — Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced restructuring actions to better align costs with current and future geographic revenue sources and to improve efficiencies. The actions, which include increasing outreach and sales and marketing efforts, […]

Cambridge-based Congenica, a spinout from The Wellcome Trust Sanger Institute, has raised a further £2.2m with the completion of a series A round of financing by Amadeus Capital Partners’ early stage funds and the company’s initial investor Cambridge Innovation Capital. Congenica was launched in 2014 by six world leading geneticists and bio-informaticians. It has developed […]

Austin, TX — VUV Analytics, Inc., manufacturers of the VGA-100 vacuum ultraviolet (VUV) detector, announced the final closing of a total $9 million Series A and venture debt financing and the addition of new CEO Clark Jernigan. The round was led by S3 Ventures. “This latest infusion of capital will further advance VUV Analytics as […]

BERKELEY, Calif. — Caribou Biosciences, a developer of CRISPR-Cas9 technologies for precision cell engineering, today announced that it has closed an $11 million Series A financing round. Investors include Fidelity Biosciences, Novartis, Mission Bay Capital, 5 Prime Ventures, and an undisclosed strategic partner. In addition, Dr. Jennifer Doudna, Investigator, Howard Hughes Medical Institute, Professor, U.C. […]

BERWYN, Pa. — AMETEK, Inc. (NYSE: AME) today announced that its Board of Directors has increased the authorized level for repurchases of its common stock by $350 million. This increased authorization will be added to the approximately $20 million that currently remains available from an existing authorization approved by the Board of Directors in November […]

LANSING, Mich. -— Neogen Corporation (NASDAQ: NEOG) announced today that Jerome Properties, LLC, has adopted a prearranged trading plan in accordance with Securities and Exchange Commission rule 10b5-1. James Herbert, Chairman and CEO of Neogen Corporation is a minority owner of this entity that owns shares of Neogen Corporation common stock. Herbert does not have […]

Jena -– Analytik Jena AG is leaving the stock exchange after almost 15 years. The shares of the Jena-based manufacturer of analytical measuring technology and life science products will no longer be listed on the regulated market of the Frankfurt Stock Exchange in the Prime Standard segment after today. “We would like to offer our […]

Palo Alto, CA — — Ayasdi, the leader in Machine Intelligence software, announced more than 400 percent bookings growth for fiscal year ended Jan 30th, 2015, and a new $55M round of Series C funding, led by Kleiner Perkins Caufield & Byers (KPCB), and joined by existing investors, Institutional Venture Partners (IVP), Khosla Ventures, FLOODGATE, […]